All In Biotech

Free tool

FAERS Monitor: Tolak

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022259 or its brand name (Tolak, Fluorouracil). Reports on generic versions are filed under their own applications.

Reports

77,744

Serious

73,787

95% of reports

Hospitalization

31,318

Death reported

10,973

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea7,085
  • neutropenia5,296
  • nausea5,071
  • vomiting4,044
  • off label use3,630
  • neuropathy peripheral3,541
  • fatigue3,324
  • disease progression3,293
  • pyrexia3,093
  • thrombocytopenia3,036
  • febrile neutropenia2,916
  • anaemia2,612
  • asthenia2,592
  • drug ineffective2,242
  • malignant neoplasm progression2,217

Reports by year received

View as table
YearReports
20041,695
20051,687
20061,392
20071,586
20081,848
20091,815
20101,692
20112,338
20122,862
20132,240
20141,876
20152,381
20162,755
20173,206
20184,849
20195,101
20204,268
20214,269
20225,740
20236,336
20246,005
20256,709
20265,094

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,976,415 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal2,91612.411.929,282
neutropeniaSignal5,29610.910.646,176
neuropathy peripheralSignal3,54110.410.129,160
disease progressionSignal3,2937.77.518,813
thrombocytopeniaSignal3,0367.57.316,785
malignant neoplasm progressionSignal2,2176.05.79,001
anaemiaSignal2,6123.73.65,222
diarrhoeaSignal7,0853.02.99,581
pyrexiaSignal3,0932.42.32,624
vomitingSignal4,0442.32.33,140
asthenia2,5921.91.81,062
nausea5,0711.71.71,640
fatigue3,3241.21.172
off label use3,6301.11.150
drug ineffective2,2420.50.41,519

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.